Charmacy Pharmaceutical Co (HKSE:02289) Capex-to-Revenue : 0.01 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Charmacy Pharmaceutical Co's Capital Expenditure for the six months ended in Dec. 2023 was HK$-11.67 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$2,334.74 Mil.

Hence, Charmacy Pharmaceutical Co's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.01.

Charmacy Pharmaceutical Co Capex-to-Revenue Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Capex-to-Revenue Chart

Charmacy Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

Get a 7-Day Free Trial

0.02

0.01

Charmacy Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial														-	-	-	0.01	0.01

Competitive Comparison of Charmacy Pharmaceutical Co's Capex-to-Revenue

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Charmacy Pharmaceutical Co's Capex-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Capex-to-Revenue falls into.

Charmacy Pharmaceutical Co Capex-to-Revenue Calculation

Charmacy Pharmaceutical Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-44.68)	/	4816.601
	=	0.01

Charmacy Pharmaceutical Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-11.672)	/	2334.736
	=	0.00

Charmacy Pharmaceutical Co (HKSE:02289) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Charmacy Pharmaceutical Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

https://www.chmyy.com

Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.

Executives

Jiangxi Pharmaceutical Investment Co., Limited	2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Yao Chuanglong	2101 Beneficial owner
You Zeyan	2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si	2101 Beneficial owner
Rays Capital Partners Limited	2102 Investment manager
Ruan David Ching Chi	2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited	2101 Beneficial owner
Wang Yonghui	2101 Beneficial owner

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines